[Dietary intake and dyslipidemia arising from combination antiretroviral therapy for HIV infection: a systematic review]

Arq Bras Endocrinol Metabol. 2009 Jul;53(5):519-27. doi: 10.1590/s0004-27302009000500005.
[Article in Portuguese]

Abstract

To review and synthesize the available scientific evidence on the relationship between dietary intake and dyslipidemias in HIV-infected patients in combination antiretroviral therapy (ART). A systematic review of literature was carried out. Original and published studies were investigated and two categories of dietary exposure were considered: energy and nutrient intake, and consumption of a test diet. A narrative review of included studies was conducted. The findings were summarized according to category of metabolic outcomes (effect on total cholesterol and LDL-c, effect on HDL-c and effect on triglycerides). Twenty original studies were included in this review, being 13 clinical trials and 7 observational studies. Omega-3 fatty acid supplementation led to a significant decrease in triglycerides. There was very little evidence on the effectiveness of dietary interventions for the prevention and control of dyslipidemias in HIV-infected patients receiving ART.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Clinical Trials as Topic
  • Diet*
  • Dyslipidemias / blood
  • Dyslipidemias / chemically induced
  • Dyslipidemias / prevention & control*
  • Energy Intake
  • Evidence-Based Medicine*
  • Feeding Behavior
  • HIV Infections / diet therapy
  • HIV Infections / drug therapy*
  • Humans
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Triglycerides